Patient-level meta-analysis of 1y phase 3a EDITION type 2 diabetes mellitus studies: glycaemic control and hypoglycaemia with insulin glargine 300 U/ml (Gla-300) vs glargine 100 U/ml (Gla-100)

被引：0
|
作者：
Ritzel, R. A. [1 ]
Roussel, R. [2 ]
Giaccari, A. [3 ]
Vora, J. [4 ]
Grisoni, M. -L. [5 ]
Brulle-Wohlhueter, C. [6 ]
Glezer, S. [6 ]
Yki-Jarvinen, H. [7 ]
机构：
[1] Stadt Klinikum Munchen GmbH, Klinikum Schwabing, Munich, Germany
[2] Hop Xavier Bichat, AP HP, Paris, France
[3] Univ Cattolica Sacro Cuore, Endocrinometab Dis Unit, Rome, Italy
[4] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England
[5] AIXIAL, Levallois Perret, France
[6] Sanofi, Paris, France
[7] Univ Helsinki, FIN-00014 Helsinki, Finland
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
975
引用
收藏
页码：S472 / S472
页数：1
相关论文
共 50 条
  • [1] The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100) in people with type 2 diabetes: A patient-level meta-analysis of EDITION 2 and 3
    Yale, Jean-Francois
    Pettus, Jeremy Hodson
    Brito-Sanfiel, Miguel
    Lavalle-Gonzalez, Fernando
    Merino-Trigo, Ana
    Stella, Peter
    Chevalier, Soazig
    Buzzetti, Raffaella
    [J]. PLOS ONE, 2018, 13 (01):
  • [2] Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL (Gla-300) vs. Glargine 100 U/mL (Gla-100) in Type 2 Diabetes (T2DM) in a Patient-Level Meta-analysis of 1-Yr Phase 3a EDITION Studies
    Ritzel, Robert
    Roussel, Ronan
    Giaccari, Andrea
    Vora, Jiten P.
    Grisoni, Marie-Lise
    Brulle-Wohlhueter, Claire
    Glezer, Stanislav
    Yki-Jazrvinen, Hannele
    [J]. DIABETES, 2015, 64 : A264 - A264
  • [3] The efficacy of switching from Insulin Glargine 100 U/mL (Gla-100) to Insulin Glargine 300 U/mL (Gla-300) in patients with type 2 diabetes mellitus
    Yang, K. -H.
    Tseng, C. -T.
    Chen, L. -C.
    Chen, P. -C.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 310 - 310
  • [4] New insulin glargine 300U/ml (Gla-300): glycaemic control and hypoglycaemia in insulin-naive people with Type 2 diabetes compared with glargine 100U/ml (Gla-100)
    Bolli, G. B.
    Riddle, M. C.
    Bergenstal, R. M.
    Sestakauskas, K.
    Goyeau, H.
    Home, P. D.
    [J]. DIABETIC MEDICINE, 2015, 32 : 78 - 78
  • [5] Is hypoglycaemia a modifiable patient risk in type 2 diabetes: A pooled analysis of insulin glargine 300 U/mL (Gla-300) vs 100U/mL (Gla-100) trials?
    Zhang, Q.
    Rosenstock, J.
    Gerrits, C.
    Liao, L.
    Chew, P.
    [J]. DIABETOLOGIA, 2015, 58 : S472 - S472
  • [6] Is Hypoglycemia a Modifiable Patient Risk in Type 2 Diabetes? A Pooled Analysis of Insulin Glargine 300U/mL (Gla-300) vs. 100U/mL (Gla-100) Trials
    Rosenstock, Julio
    Zhang, Quanwu
    Gerrits, Charles
    Liao, Laura
    Chew, Paul
    [J]. DIABETES, 2015, 64 : A110 - A110
  • [7] Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes
    Ritzel, R.
    Roussel, R.
    Bolli, G. B.
    Vinet, L.
    Brulle-Wohlhueter, C.
    Glezer, S.
    Yki-Jaervinen, H.
    [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (09): : 859 - 867
  • [8] SWITCHING TO INSULIN GLARGINE 300 U/ML (GLA-300): BENEFITS VS GLA-100 BY DURATION OF PRIOR BASAL INSULIN THERAPY
    Bonadonna, R. C.
    Renard, E.
    Cheng, A.
    Fritsche, A.
    Glezer, S.
    Cali, A.
    Grisoni, M. L.
    Umpierrez, G.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A31 - A31
  • [9] INSULIN GLARGINE 300 U/ML (GLA-300) VS 100 U/ML (GLA-100) IN OLDER PEOPLE WITH T2DM: RESULTS FROM A RANDOMIZED TRIAL
    Ritzel, R.
    Espinasse, M.
    Muehlen-Bartmer, I.
    Zhang, N.
    Munshi, M.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A135 - A136
  • [10] Insulin Glargine 300 U/mL (Gla-300) vs 100 U/mL (Gla-100) in older people with T2Dm: Results from a randomized trial
    Ritzel, Robert
    Vonbank, Alexander
    Espinasse, Melanie
    Muehlen-Bartmer, Ingrid
    Zhang, Nue
    Munshi, Medha
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 369 - 369
12345